Renovaro Biosciences Inc (RENB)
US$ 0.91711.17%
Price Chart
Key Statistics
Market Cap
$ 60.54M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
530.85K
52W High
$ 2.10
52W Low
$ 0.32
Dividend Yield
0.00%
Beta
0.58
Technicals
50-Day MA
0.664
200-Day MA
0.7776
52 Week High
2.1
52 Week Low
0.321
About RENB
Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherl.
Employees
25
Headquarters
Los Angeles, CA
CEO
Dr. Francois Binette M.Sc., Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg